Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?

Kandemir NO, Barut F, Bektas S, Ozdamar SO.

Pathol Oncol Res. 2012 Apr;18(2):253-62. doi: 10.1007/s12253-011-9436-1. Epub 2011 Jul 23.

PMID:
21785902
2.
3.

Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Zhao YC, Ni XJ, Li Y, Dai M, Yuan ZX, Zhu YY, Luo CY.

World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.

4.
5.
6.

Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.

El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ.

Am J Clin Pathol. 2008 Apr;129(4):578-86. doi: 10.1309/2HGNJ1GU57JMBJAQ.

PMID:
18343785
7.

Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.

Saad RS, Ismiil N, Ghorab Z, Nofech-Mozes S, Dubé V, Covens A, Khalifa MA.

Int J Gynecol Pathol. 2010 Jul;29(4):386-93. doi: 10.1097/PGP.0b013e3181c3cd47.

PMID:
20567154
8.

Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.

Xiong Y, Cao LP, Rao HL, Cai MY, Liang LZ, Liu JH.

Cell Tissue Res. 2012 Jun;348(3):515-22. doi: 10.1007/s00441-012-1384-x. Epub 2012 Apr 11.

PMID:
22492093
9.

Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer.

Lin M, Ma SP, Lin HZ, Ji P, Xie D, Yu JX.

Clin Exp Metastasis. 2010 Mar;27(3):123-32. doi: 10.1007/s10585-010-9309-0. Epub 2010 Mar 2.

PMID:
20195706
10.

Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.

Coşkun U, Akyürek N, Dursun A, Yamaç D.

J Surg Res. 2010 Nov;164(1):110-5. doi: 10.1016/j.jss.2009.03.081. Epub 2009 May 3.

PMID:
19628230
11.
12.

Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.

Faoro L, Hutto JY, Salgia R, El-Zayaty SA, Ferguson MK, Cheney RT, Reid ME, Armato SG 3rd, Krausz T, Husain AN.

Arch Pathol Lab Med. 2008 Dec;132(12):1882-8. doi: 10.1043/1543-2165-132.12.1882.

PMID:
19061284
13.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

14.

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.

Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN.

Mod Pathol. 2007 Feb;20(2):183-91. Epub 2007 Jan 5.

15.

Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.

Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.

Breast Cancer Res Treat. 2005 May;91(2):125-32.

PMID:
15868440
16.

Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: an immunohistochemical study.

Maghraby HK, Elsarha AI, Saad RS.

Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):465-9. doi: 10.4103/0377-4929.68278.

17.

Lymphatic microvessel density as prognostic marker in colorectal cancer.

Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF.

Mod Pathol. 2006 Oct;19(10):1317-23. Epub 2006 Jun 23.

18.

Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma.

Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS.

Ann Surg Oncol. 2010 Jan;17(1):73-80. doi: 10.1245/s10434-009-0707-y. Epub 2009 Sep 24.

PMID:
19777179
19.

Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.

Donizy P, Rudno-Rudzinska J, Halon A, Dziegala M, Kabarowski J, Frejlich E, Dziegiel P, Kielan W, Matkowski R.

Anticancer Res. 2014 Jun;34(6):3113-8.

PMID:
24922680
20.

Supplemental Content

Support Center